Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026
Source: SeekingAlpha
2026-01-26 22:40:08 ET
...
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
0.77% G/L:
$28.63 Last:
208,835 Volume:
$28.29 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
